GlassScriptPhysician profile
Prathima Nagireddy
NPI 1306133731
$1,795.44
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Public Health & General Preventive Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $79.24 · 2023: $969 · 2024: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,716.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $946.44 | 2022-2024 | Dovato, Cabenuva, Apretude |
| Gilead Sciences, INC. | $281.91 | 2022-2024 | |
| Janssen Biotech, INC. | $165.46 | 2022-2023 | Symtuza |
| Merck Sharp & Dohme LLC | $157.56 | 2023-2024 | Delstrigo, Pifeltro, Dificid |
| Emd Serono, INC. | $86.84 | 2024 | |
| Theratechnologies INC. | $82.04 | 2023-2024 | Trogarzo, Egrifta |
| Napo Pharmaceuticals INC | $39.04 | 2023-2024 | Mytesi |
| Insmed, INC. | $19.14 | 2023 | Arikayce |
| Novo Nordisk INC | $17.01 | 2023 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prathima Nagireddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.